Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Renal Insufficiency, Chronic | 52 | 2022 | 1994 | 4.000 |
Why?
|
Kidney Failure, Chronic | 32 | 2022 | 2570 | 3.020 |
Why?
|
Renal Dialysis | 17 | 2022 | 1749 | 2.760 |
Why?
|
Diabetic Nephropathies | 13 | 2022 | 1039 | 2.360 |
Why?
|
Calcinosis | 9 | 2013 | 1456 | 1.860 |
Why?
|
Kidney Transplantation | 17 | 2021 | 4141 | 1.800 |
Why?
|
Coronary Artery Disease | 12 | 2022 | 6313 | 1.260 |
Why?
|
Erectile Dysfunction | 4 | 2021 | 448 | 1.130 |
Why?
|
Glomerular Filtration Rate | 27 | 2022 | 2105 | 0.990 |
Why?
|
Renal Replacement Therapy | 2 | 2021 | 256 | 0.700 |
Why?
|
Cardiovascular Diseases | 21 | 2022 | 14381 | 0.630 |
Why?
|
Diabetes Mellitus | 8 | 2022 | 5452 | 0.630 |
Why?
|
Interleukin-6 | 5 | 2022 | 3216 | 0.630 |
Why?
|
Kidney Diseases | 9 | 2020 | 2131 | 0.620 |
Why?
|
Lipoprotein(a) | 3 | 2007 | 395 | 0.570 |
Why?
|
Arteriovenous Shunt, Surgical | 3 | 2017 | 243 | 0.550 |
Why?
|
Fibroblast Growth Factors | 4 | 2016 | 887 | 0.480 |
Why?
|
Albuminuria | 9 | 2022 | 674 | 0.470 |
Why?
|
Disease Progression | 21 | 2022 | 13307 | 0.460 |
Why?
|
Health Literacy | 3 | 2014 | 395 | 0.450 |
Why?
|
Coronary Vessels | 4 | 2014 | 2988 | 0.450 |
Why?
|
C-Reactive Protein | 4 | 2021 | 3710 | 0.440 |
Why?
|
Kidney | 13 | 2022 | 6910 | 0.430 |
Why?
|
Heart Valves | 1 | 2013 | 294 | 0.420 |
Why?
|
Catheters, Indwelling | 2 | 2012 | 426 | 0.410 |
Why?
|
Polytetrafluoroethylene | 1 | 2012 | 239 | 0.410 |
Why?
|
Diabetes Mellitus, Type 2 | 10 | 2022 | 11008 | 0.390 |
Why?
|
Hypertriglyceridemia | 2 | 2003 | 296 | 0.350 |
Why?
|
Middle Aged | 67 | 2022 | 215041 | 0.340 |
Why?
|
United States Government Agencies | 1 | 2008 | 27 | 0.340 |
Why?
|
Allopurinol | 2 | 2020 | 202 | 0.340 |
Why?
|
Cohort Studies | 31 | 2022 | 39887 | 0.340 |
Why?
|
Prospective Studies | 32 | 2022 | 51275 | 0.330 |
Why?
|
Humans | 116 | 2022 | 717237 | 0.330 |
Why?
|
Diabetes Mellitus, Type 1 | 5 | 2022 | 3368 | 0.320 |
Why?
|
Minority Health | 1 | 2008 | 84 | 0.310 |
Why?
|
Tunica Intima | 1 | 2009 | 501 | 0.310 |
Why?
|
Glaucoma | 1 | 2015 | 993 | 0.310 |
Why?
|
Adult | 57 | 2022 | 212451 | 0.310 |
Why?
|
Blood Pressure | 5 | 2021 | 8583 | 0.300 |
Why?
|
Male | 72 | 2022 | 351380 | 0.290 |
Why?
|
Uric Acid | 3 | 2022 | 740 | 0.290 |
Why?
|
Cholesterol, HDL | 3 | 2014 | 1840 | 0.280 |
Why?
|
Heart Valve Diseases | 1 | 2013 | 1057 | 0.280 |
Why?
|
Carotid Stenosis | 1 | 2012 | 848 | 0.280 |
Why?
|
Kidney Function Tests | 7 | 2022 | 702 | 0.280 |
Why?
|
Aorta | 2 | 2011 | 2114 | 0.270 |
Why?
|
Carotid Arteries | 1 | 2009 | 965 | 0.270 |
Why?
|
Renin-Angiotensin System | 5 | 2020 | 763 | 0.260 |
Why?
|
Health Priorities | 1 | 2008 | 387 | 0.260 |
Why?
|
Graft Survival | 4 | 2021 | 3765 | 0.260 |
Why?
|
Proteinuria | 3 | 2019 | 630 | 0.260 |
Why?
|
Female | 68 | 2022 | 377909 | 0.250 |
Why?
|
Hyperglycemia | 2 | 2022 | 1359 | 0.250 |
Why?
|
Aged | 49 | 2021 | 162856 | 0.250 |
Why?
|
Sleep Apnea Syndromes | 1 | 2011 | 886 | 0.240 |
Why?
|
Coronary Disease | 3 | 2014 | 6127 | 0.240 |
Why?
|
Risk Factors | 31 | 2022 | 70864 | 0.240 |
Why?
|
Lipocalins | 2 | 2014 | 175 | 0.240 |
Why?
|
Aortic Diseases | 1 | 2009 | 726 | 0.230 |
Why?
|
Efficiency, Organizational | 1 | 2008 | 698 | 0.230 |
Why?
|
Myocardial Infarction | 7 | 2021 | 11423 | 0.230 |
Why?
|
Acute-Phase Proteins | 2 | 2014 | 273 | 0.230 |
Why?
|
Health Policy | 2 | 2021 | 2625 | 0.220 |
Why?
|
African Americans | 6 | 2016 | 5026 | 0.220 |
Why?
|
Organ Transplantation | 2 | 2003 | 1077 | 0.220 |
Why?
|
Resistin | 1 | 2022 | 173 | 0.220 |
Why?
|
Prevalence | 9 | 2020 | 14896 | 0.210 |
Why?
|
Peripheral Arterial Disease | 3 | 2021 | 1238 | 0.210 |
Why?
|
Coronary Stenosis | 1 | 2007 | 810 | 0.200 |
Why?
|
Inflammation | 4 | 2016 | 10116 | 0.200 |
Why?
|
Xanthine Oxidase | 1 | 2020 | 74 | 0.200 |
Why?
|
Aspartate Aminotransferases | 1 | 2021 | 411 | 0.190 |
Why?
|
Adipokines | 1 | 2022 | 307 | 0.190 |
Why?
|
Phosphodiesterase Inhibitors | 1 | 2001 | 238 | 0.190 |
Why?
|
Insulin Resistance | 1 | 2013 | 3895 | 0.190 |
Why?
|
Atherosclerosis | 3 | 2021 | 3262 | 0.190 |
Why?
|
Glomerulonephritis, Membranoproliferative | 1 | 1999 | 40 | 0.180 |
Why?
|
Troponin T | 2 | 2014 | 752 | 0.180 |
Why?
|
Spin Labels | 1 | 2020 | 314 | 0.180 |
Why?
|
Alanine Transaminase | 1 | 2021 | 599 | 0.180 |
Why?
|
Cryoglobulinemia | 1 | 1999 | 85 | 0.170 |
Why?
|
Sodium | 3 | 2022 | 1606 | 0.170 |
Why?
|
Regression Analysis | 4 | 2013 | 6481 | 0.170 |
Why?
|
Hyperlipidemias | 1 | 2003 | 805 | 0.170 |
Why?
|
United States | 23 | 2022 | 67798 | 0.170 |
Why?
|
Heart Failure | 8 | 2021 | 10185 | 0.170 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2010 | 1726 | 0.160 |
Why?
|
Acute Kidney Injury | 2 | 2021 | 1891 | 0.160 |
Why?
|
Creatinine | 5 | 2022 | 1907 | 0.160 |
Why?
|
Financing, Government | 1 | 2021 | 480 | 0.160 |
Why?
|
Renal Insufficiency | 2 | 2014 | 805 | 0.150 |
Why?
|
Research Personnel | 1 | 2021 | 520 | 0.150 |
Why?
|
Serine Endopeptidases | 1 | 2022 | 1136 | 0.150 |
Why?
|
Risk Adjustment | 1 | 2020 | 588 | 0.150 |
Why?
|
Research Support as Topic | 1 | 2021 | 720 | 0.150 |
Why?
|
Thyroid Diseases | 1 | 2000 | 387 | 0.150 |
Why?
|
Adiponectin | 1 | 2022 | 1084 | 0.140 |
Why?
|
Metformin | 1 | 2022 | 805 | 0.140 |
Why?
|
Obesity, Abdominal | 2 | 2016 | 341 | 0.140 |
Why?
|
Proportional Hazards Models | 9 | 2021 | 12417 | 0.140 |
Why?
|
Cross-Sectional Studies | 10 | 2020 | 23409 | 0.140 |
Why?
|
Hematoma | 1 | 2020 | 743 | 0.140 |
Why?
|
Body Mass Index | 5 | 2016 | 12507 | 0.140 |
Why?
|
Obesity | 4 | 2021 | 12247 | 0.140 |
Why?
|
Uromodulin | 1 | 2014 | 49 | 0.140 |
Why?
|
Exercise | 1 | 2011 | 5330 | 0.140 |
Why?
|
Health Status Disparities | 3 | 2021 | 1728 | 0.140 |
Why?
|
Hypertrophy, Left Ventricular | 4 | 2015 | 863 | 0.140 |
Why?
|
Cause of Death | 4 | 2021 | 3592 | 0.130 |
Why?
|
N-Acetylgalactosaminyltransferases | 1 | 2014 | 71 | 0.130 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2010 | 3956 | 0.130 |
Why?
|
Hepacivirus | 1 | 2021 | 1321 | 0.130 |
Why?
|
Hypoglycemic Agents | 3 | 2022 | 2779 | 0.130 |
Why?
|
Leptin | 1 | 2022 | 1580 | 0.130 |
Why?
|
Bicarbonates | 1 | 2015 | 313 | 0.130 |
Why?
|
Adiposity | 2 | 2014 | 1747 | 0.120 |
Why?
|
Incidence | 7 | 2020 | 20653 | 0.120 |
Why?
|
Diabetic Retinopathy | 1 | 2022 | 1207 | 0.120 |
Why?
|
Hypertension | 2 | 2010 | 8286 | 0.120 |
Why?
|
Kidney Tubules | 1 | 2015 | 496 | 0.120 |
Why?
|
Hepatitis C, Chronic | 1 | 2021 | 1002 | 0.120 |
Why?
|
Patient Preference | 1 | 2020 | 859 | 0.120 |
Why?
|
Fibrinogen | 2 | 2014 | 915 | 0.120 |
Why?
|
Markov Chains | 2 | 2017 | 985 | 0.110 |
Why?
|
Catheterization, Central Venous | 1 | 2017 | 511 | 0.110 |
Why?
|
Hospitalization | 5 | 2020 | 9754 | 0.110 |
Why?
|
Lymphoma, B-Cell | 1 | 1999 | 937 | 0.110 |
Why?
|
Young Adult | 15 | 2020 | 56247 | 0.110 |
Why?
|
Apolipoproteins | 1 | 2013 | 312 | 0.100 |
Why?
|
Potassium | 1 | 2015 | 1332 | 0.100 |
Why?
|
Intra-Abdominal Fat | 1 | 2016 | 581 | 0.100 |
Why?
|
Osteoprotegerin | 1 | 2011 | 176 | 0.100 |
Why?
|
Health Care Costs | 2 | 2017 | 3179 | 0.100 |
Why?
|
Proto-Oncogene Proteins | 2 | 2014 | 4697 | 0.100 |
Why?
|
Waist-Hip Ratio | 1 | 2012 | 524 | 0.100 |
Why?
|
Pulsatile Flow | 1 | 2011 | 338 | 0.100 |
Why?
|
Quality of Health Care | 2 | 2018 | 4286 | 0.100 |
Why?
|
Polymorphism, Single Nucleotide | 6 | 2017 | 15600 | 0.100 |
Why?
|
Polycystic Kidney Diseases | 1 | 2010 | 127 | 0.100 |
Why?
|
Intraocular Pressure | 1 | 2015 | 1165 | 0.100 |
Why?
|
Tomography, X-Ray Computed | 7 | 2017 | 20434 | 0.100 |
Why?
|
Cataract | 1 | 2015 | 782 | 0.100 |
Why?
|
Quality-Adjusted Life Years | 2 | 2017 | 1615 | 0.100 |
Why?
|
Immunosuppressive Agents | 3 | 2010 | 4208 | 0.100 |
Why?
|
Piperazines | 1 | 2001 | 2543 | 0.090 |
Why?
|
Multivariate Analysis | 6 | 2016 | 12483 | 0.090 |
Why?
|
Cadherins | 1 | 2014 | 917 | 0.090 |
Why?
|
Ultrasonography, Doppler, Color | 1 | 2010 | 234 | 0.090 |
Why?
|
Postoperative Complications | 3 | 2008 | 15126 | 0.090 |
Why?
|
Pulse | 1 | 2009 | 234 | 0.090 |
Why?
|
Acculturation | 1 | 2010 | 167 | 0.090 |
Why?
|
Natriuretic Peptide, Brain | 2 | 2015 | 1578 | 0.090 |
Why?
|
Consensus | 3 | 2022 | 2755 | 0.090 |
Why?
|
Inflammation Mediators | 2 | 2016 | 1948 | 0.090 |
Why?
|
Enzyme Inhibitors | 1 | 2020 | 3933 | 0.090 |
Why?
|
Survival Analysis | 3 | 2018 | 10542 | 0.090 |
Why?
|
Lipoproteins, HDL | 1 | 2013 | 652 | 0.090 |
Why?
|
Graft Occlusion, Vascular | 1 | 2012 | 525 | 0.090 |
Why?
|
Histocompatibility Testing | 2 | 2008 | 804 | 0.090 |
Why?
|
Health Expenditures | 1 | 2021 | 2266 | 0.090 |
Why?
|
Risk Assessment | 8 | 2021 | 23542 | 0.090 |
Why?
|
Smoking | 3 | 2016 | 8948 | 0.090 |
Why?
|
Healthcare Disparities | 2 | 2021 | 3031 | 0.080 |
Why?
|
Ankle Brachial Index | 2 | 2021 | 166 | 0.080 |
Why?
|
Chromosome Mapping | 1 | 2017 | 4825 | 0.080 |
Why?
|
Membrane Proteins | 2 | 2022 | 8109 | 0.080 |
Why?
|
DNA Methylation | 1 | 2021 | 4102 | 0.080 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2017 | 1318 | 0.080 |
Why?
|
Fatty Liver | 1 | 2013 | 716 | 0.080 |
Why?
|
Sympathetic Nervous System | 1 | 2010 | 533 | 0.080 |
Why?
|
Quality of Life | 3 | 2021 | 11760 | 0.080 |
Why?
|
Comorbidity | 4 | 2017 | 10451 | 0.080 |
Why?
|
Genetic Loci | 1 | 2017 | 2614 | 0.080 |
Why?
|
Stroke | 3 | 2021 | 9512 | 0.080 |
Why?
|
Time Factors | 8 | 2018 | 41095 | 0.080 |
Why?
|
Morbidity | 1 | 2012 | 1706 | 0.080 |
Why?
|
Tacrolimus | 1 | 2010 | 715 | 0.080 |
Why?
|
Hypolipidemic Agents | 2 | 2003 | 615 | 0.080 |
Why?
|
Postmenopause | 1 | 2016 | 2419 | 0.080 |
Why?
|
Lipids | 2 | 2008 | 3269 | 0.080 |
Why?
|
Statistics as Topic | 1 | 2013 | 2405 | 0.070 |
Why?
|
Community-Institutional Relations | 1 | 2008 | 207 | 0.070 |
Why?
|
Vasodilation | 1 | 2010 | 966 | 0.070 |
Why?
|
Women's Health | 1 | 2016 | 1934 | 0.070 |
Why?
|
HLA-A Antigens | 1 | 2007 | 253 | 0.070 |
Why?
|
Follow-Up Studies | 6 | 2014 | 39302 | 0.070 |
Why?
|
Nephrology | 2 | 2021 | 240 | 0.070 |
Why?
|
Health Promotion | 1 | 2018 | 2189 | 0.070 |
Why?
|
Drug Utilization | 1 | 2012 | 1223 | 0.070 |
Why?
|
Hemodynamics | 2 | 2020 | 4231 | 0.070 |
Why?
|
Odds Ratio | 4 | 2021 | 9974 | 0.070 |
Why?
|
Treatment Failure | 2 | 2020 | 2678 | 0.070 |
Why?
|
HLA-B Antigens | 1 | 2007 | 384 | 0.070 |
Why?
|
Biomedical Research | 1 | 2021 | 3273 | 0.070 |
Why?
|
Monitoring, Physiologic | 1 | 2013 | 1762 | 0.070 |
Why?
|
Pain | 1 | 2020 | 4692 | 0.070 |
Why?
|
Prognosis | 6 | 2016 | 29226 | 0.070 |
Why?
|
HLA-DR Antigens | 1 | 2007 | 693 | 0.070 |
Why?
|
Peptide Fragments | 2 | 2015 | 5160 | 0.070 |
Why?
|
Genetic Predisposition to Disease | 3 | 2016 | 17432 | 0.070 |
Why?
|
Predictive Value of Tests | 4 | 2014 | 15271 | 0.070 |
Why?
|
Insulin | 1 | 2020 | 6691 | 0.070 |
Why?
|
Alleles | 1 | 2016 | 7101 | 0.070 |
Why?
|
Triglycerides | 2 | 2014 | 2591 | 0.070 |
Why?
|
Genome-Wide Association Study | 7 | 2017 | 11951 | 0.060 |
Why?
|
Computational Biology | 1 | 2017 | 3568 | 0.060 |
Why?
|
Mycophenolic Acid | 1 | 2006 | 345 | 0.060 |
Why?
|
Fasting | 1 | 2010 | 1622 | 0.060 |
Why?
|
Genotype | 5 | 2022 | 12923 | 0.060 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2010 | 935 | 0.060 |
Why?
|
Dyslipidemias | 1 | 2012 | 849 | 0.060 |
Why?
|
Calcium | 2 | 2014 | 5832 | 0.060 |
Why?
|
Sleep Deprivation | 1 | 2010 | 809 | 0.060 |
Why?
|
Sex Factors | 4 | 2021 | 10660 | 0.060 |
Why?
|
Cardiomyopathies | 1 | 2015 | 1831 | 0.060 |
Why?
|
Cost-Benefit Analysis | 2 | 2017 | 5268 | 0.060 |
Why?
|
Transplantation, Homologous | 2 | 2008 | 4846 | 0.060 |
Why?
|
Role | 1 | 2003 | 178 | 0.060 |
Why?
|
Amino Acids | 1 | 2008 | 1753 | 0.060 |
Why?
|
Cathepsin D | 1 | 2022 | 66 | 0.060 |
Why?
|
Angiopoietin-1 | 1 | 2022 | 123 | 0.060 |
Why?
|
HLA Antigens | 1 | 2008 | 1552 | 0.060 |
Why?
|
Angiopoietins | 1 | 2022 | 91 | 0.060 |
Why?
|
Vitamin K 1 | 1 | 2022 | 46 | 0.060 |
Why?
|
Receptor, TIE-2 | 1 | 2022 | 188 | 0.060 |
Why?
|
Naphthyridines | 1 | 2022 | 120 | 0.060 |
Why?
|
Educational Status | 1 | 2010 | 2340 | 0.060 |
Why?
|
Mortality | 3 | 2021 | 2796 | 0.060 |
Why?
|
Echocardiography | 2 | 2015 | 5099 | 0.060 |
Why?
|
Angiopoietin-2 | 1 | 2022 | 167 | 0.050 |
Why?
|
Iohexol | 1 | 2022 | 202 | 0.050 |
Why?
|
Hemodialysis, Home | 1 | 2021 | 20 | 0.050 |
Why?
|
Primary Health Care | 1 | 2018 | 4542 | 0.050 |
Why?
|
Longitudinal Studies | 4 | 2021 | 13612 | 0.050 |
Why?
|
Energy Metabolism | 1 | 2013 | 2977 | 0.050 |
Why?
|
Reoperation | 1 | 2012 | 4186 | 0.050 |
Why?
|
Treatment Refusal | 1 | 2005 | 421 | 0.050 |
Why?
|
Guideline Adherence | 1 | 2012 | 2334 | 0.050 |
Why?
|
Myocardium | 1 | 2015 | 4943 | 0.050 |
Why?
|
Radial Artery | 1 | 2003 | 204 | 0.050 |
Why?
|
Logistic Models | 4 | 2021 | 13601 | 0.050 |
Why?
|
Coronary Angiography | 2 | 2018 | 4419 | 0.050 |
Why?
|
Hypertension, Renal | 1 | 2001 | 180 | 0.050 |
Why?
|
Decision Support Techniques | 1 | 2012 | 2043 | 0.050 |
Why?
|
Health Education | 1 | 2008 | 1061 | 0.050 |
Why?
|
Cystatin C | 2 | 2012 | 247 | 0.050 |
Why?
|
Glucagon-Like Peptide 1 | 1 | 2022 | 313 | 0.050 |
Why?
|
Health Facilities | 1 | 2005 | 467 | 0.050 |
Why?
|
Intermittent Claudication | 1 | 2003 | 339 | 0.050 |
Why?
|
Survival Rate | 2 | 2013 | 13261 | 0.050 |
Why?
|
Adolescent | 6 | 2020 | 85139 | 0.050 |
Why?
|
Vascular Patency | 1 | 2003 | 907 | 0.050 |
Why?
|
Age Factors | 3 | 2017 | 18798 | 0.050 |
Why?
|
Glucose | 2 | 2022 | 4303 | 0.050 |
Why?
|
Hemostasis, Surgical | 1 | 2020 | 128 | 0.050 |
Why?
|
Treatment Outcome | 5 | 2018 | 62348 | 0.050 |
Why?
|
Phenotype | 1 | 2018 | 16404 | 0.050 |
Why?
|
Medicare | 2 | 2021 | 5787 | 0.050 |
Why?
|
Patient Discharge | 1 | 2012 | 3031 | 0.050 |
Why?
|
Life Style | 1 | 2011 | 3719 | 0.050 |
Why?
|
Interferon Regulatory Factors | 1 | 2021 | 281 | 0.050 |
Why?
|
Nutrition Surveys | 2 | 2018 | 1572 | 0.050 |
Why?
|
Blood Glucose | 2 | 2014 | 6296 | 0.050 |
Why?
|
Albumins | 1 | 2022 | 567 | 0.050 |
Why?
|
Vitamin K | 1 | 2022 | 283 | 0.050 |
Why?
|
Gene Frequency | 2 | 2017 | 3714 | 0.050 |
Why?
|
Protective Agents | 1 | 2020 | 165 | 0.050 |
Why?
|
Heart Diseases | 1 | 2012 | 2762 | 0.050 |
Why?
|
Hematuria | 1 | 2020 | 235 | 0.050 |
Why?
|
Glomerular Mesangium | 1 | 1999 | 105 | 0.040 |
Why?
|
Risk | 1 | 2011 | 9773 | 0.040 |
Why?
|
Proteomics | 2 | 2022 | 3268 | 0.040 |
Why?
|
Medicaid | 1 | 2012 | 2635 | 0.040 |
Why?
|
Hospital Mortality | 1 | 2012 | 5141 | 0.040 |
Why?
|
Public Health | 2 | 2021 | 2395 | 0.040 |
Why?
|
Linear Models | 3 | 2014 | 5981 | 0.040 |
Why?
|
Sulfones | 1 | 2001 | 459 | 0.040 |
Why?
|
Parathyroid Hormone | 2 | 2017 | 1819 | 0.040 |
Why?
|
Polymorphism, Genetic | 1 | 2008 | 4352 | 0.040 |
Why?
|
Endothelium, Vascular | 1 | 2010 | 4636 | 0.040 |
Why?
|
Aged, 80 and over | 6 | 2019 | 58528 | 0.040 |
Why?
|
Anemia | 1 | 2006 | 1418 | 0.040 |
Why?
|
Education | 1 | 2020 | 546 | 0.040 |
Why?
|
CpG Islands | 1 | 2021 | 1162 | 0.040 |
Why?
|
Purines | 1 | 2001 | 600 | 0.040 |
Why?
|
Models, Biological | 1 | 2014 | 9892 | 0.040 |
Why?
|
Case-Control Studies | 3 | 2022 | 21805 | 0.040 |
Why?
|
Chi-Square Distribution | 2 | 2015 | 3565 | 0.040 |
Why?
|
Cathepsin C | 1 | 2015 | 3 | 0.040 |
Why?
|
Mood Disorders | 1 | 2003 | 1105 | 0.040 |
Why?
|
Cuba | 1 | 2015 | 45 | 0.040 |
Why?
|
Central America | 1 | 2015 | 70 | 0.040 |
Why?
|
Dominican Republic | 1 | 2015 | 70 | 0.040 |
Why?
|
Ultrasonography | 1 | 2009 | 5948 | 0.040 |
Why?
|
Europe | 1 | 2022 | 3349 | 0.040 |
Why?
|
Interpersonal Relations | 1 | 2003 | 1412 | 0.040 |
Why?
|
Urinalysis | 1 | 2018 | 363 | 0.040 |
Why?
|
Double-Blind Method | 2 | 2020 | 11910 | 0.040 |
Why?
|
South America | 1 | 2015 | 181 | 0.040 |
Why?
|
Cultural Competency | 1 | 2018 | 278 | 0.040 |
Why?
|
Communication Barriers | 1 | 2018 | 380 | 0.030 |
Why?
|
Sulfotransferases | 1 | 2015 | 138 | 0.030 |
Why?
|
Informed Consent | 1 | 2021 | 958 | 0.030 |
Why?
|
Practice Guidelines as Topic | 1 | 2012 | 7486 | 0.030 |
Why?
|
Puerto Rico | 1 | 2015 | 335 | 0.030 |
Why?
|
Mississippi | 1 | 2014 | 98 | 0.030 |
Why?
|
Hypercalcemia | 1 | 2017 | 428 | 0.030 |
Why?
|
Up-Regulation | 2 | 2016 | 4356 | 0.030 |
Why?
|
Blood Transfusion | 1 | 2020 | 1258 | 0.030 |
Why?
|
Trust | 1 | 2018 | 488 | 0.030 |
Why?
|
Delayed Graft Function | 1 | 2014 | 46 | 0.030 |
Why?
|
rab GTP-Binding Proteins | 1 | 2015 | 242 | 0.030 |
Why?
|
Socioeconomic Factors | 2 | 2021 | 7734 | 0.030 |
Why?
|
Mexico | 1 | 2015 | 679 | 0.030 |
Why?
|
Biopsy, Needle | 1 | 1999 | 1679 | 0.030 |
Why?
|
Indians, North American | 1 | 2017 | 364 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 1 | 2020 | 34502 | 0.030 |
Why?
|
Health Surveys | 1 | 2003 | 4023 | 0.030 |
Why?
|
Models, Economic | 1 | 2017 | 723 | 0.030 |
Why?
|
Gene Knockout Techniques | 1 | 2015 | 817 | 0.030 |
Why?
|
Interleukin 1 Receptor Antagonist Protein | 1 | 2014 | 299 | 0.030 |
Why?
|
Genome, Human | 2 | 2017 | 4472 | 0.030 |
Why?
|
Diuretics | 1 | 2015 | 584 | 0.030 |
Why?
|
Hospital Bed Capacity | 1 | 2012 | 199 | 0.030 |
Why?
|
Monte Carlo Method | 1 | 2017 | 1306 | 0.030 |
Why?
|
Research | 1 | 2020 | 2022 | 0.030 |
Why?
|
Emotions | 1 | 2003 | 2451 | 0.030 |
Why?
|
Animals | 5 | 2022 | 170890 | 0.030 |
Why?
|
Receptors, Fibroblast Growth Factor | 1 | 2011 | 188 | 0.030 |
Why?
|
Serum Albumin | 1 | 2014 | 682 | 0.030 |
Why?
|
Life Expectancy | 1 | 2017 | 1124 | 0.020 |
Why?
|
Electric Impedance | 1 | 2014 | 655 | 0.020 |
Why?
|
Language | 1 | 2018 | 1260 | 0.020 |
Why?
|
Absorptiometry, Photon | 1 | 2016 | 1707 | 0.020 |
Why?
|
Glucuronidase | 1 | 2011 | 233 | 0.020 |
Why?
|
Carotid Artery, Common | 1 | 2010 | 193 | 0.020 |
Why?
|
Mental Health | 1 | 2003 | 2655 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2022 | 3433 | 0.020 |
Why?
|
Living Donors | 1 | 2014 | 574 | 0.020 |
Why?
|
Myocardial Contraction | 1 | 2015 | 1649 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2021 | 2797 | 0.020 |
Why?
|
Glucocorticoids | 1 | 1999 | 2108 | 0.020 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2011 | 634 | 0.020 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2015 | 1234 | 0.020 |
Why?
|
Societies, Medical | 1 | 2021 | 3776 | 0.020 |
Why?
|
Hepatitis C | 1 | 1999 | 1518 | 0.020 |
Why?
|
Phosphates | 1 | 2012 | 786 | 0.020 |
Why?
|
Interleukin-1beta | 1 | 2014 | 966 | 0.020 |
Why?
|
Myocardial Revascularization | 1 | 2012 | 847 | 0.020 |
Why?
|
Interleukin-10 | 1 | 2014 | 1211 | 0.020 |
Why?
|
Regional Blood Flow | 1 | 2011 | 1568 | 0.020 |
Why?
|
Histocompatibility | 1 | 2008 | 362 | 0.020 |
Why?
|
Receptor, Angiotensin, Type 1 | 1 | 2007 | 155 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2000 | 8923 | 0.020 |
Why?
|
Pilot Projects | 1 | 2020 | 8066 | 0.020 |
Why?
|
Rats | 2 | 2015 | 25091 | 0.020 |
Why?
|
Pennsylvania | 1 | 2007 | 656 | 0.020 |
Why?
|
Models, Cardiovascular | 1 | 2011 | 1005 | 0.020 |
Why?
|
Receptors, Cell Surface | 1 | 2015 | 2918 | 0.020 |
Why?
|
Transforming Growth Factor beta | 1 | 2014 | 1997 | 0.020 |
Why?
|
Tibia | 1 | 2011 | 1040 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2016 | 6778 | 0.020 |
Why?
|
Cognition | 1 | 2022 | 6109 | 0.020 |
Why?
|
Physician-Patient Relations | 1 | 2018 | 3323 | 0.020 |
Why?
|
Signal Transduction | 2 | 2022 | 23996 | 0.020 |
Why?
|
Patient Selection | 1 | 2017 | 4321 | 0.020 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2015 | 2039 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 3968 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2013 | 19538 | 0.020 |
Why?
|
Depression | 1 | 2003 | 7280 | 0.020 |
Why?
|
Health Services Accessibility | 1 | 2021 | 5028 | 0.020 |
Why?
|
Poverty | 1 | 2015 | 2587 | 0.020 |
Why?
|
Computer Simulation | 1 | 2017 | 6099 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 1999 | 13274 | 0.010 |
Why?
|
Drug Prescriptions | 1 | 2012 | 1675 | 0.010 |
Why?
|
Cadaver | 1 | 2007 | 1375 | 0.010 |
Why?
|
Myocytes, Cardiac | 1 | 2011 | 1645 | 0.010 |
Why?
|
Ventricular Function, Left | 1 | 2015 | 3433 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2011 | 6528 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2014 | 4480 | 0.010 |
Why?
|
Amino Acid Substitution | 1 | 2007 | 1836 | 0.010 |
Why?
|
Transcription Factors | 1 | 2021 | 12073 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2011 | 6860 | 0.010 |
Why?
|
Mice | 2 | 2022 | 81126 | 0.010 |
Why?
|
Stroke Volume | 1 | 2012 | 4589 | 0.010 |
Why?
|
Retrospective Studies | 3 | 2014 | 72614 | 0.010 |
Why?
|
Epidemiologic Methods | 1 | 2003 | 1366 | 0.010 |
Why?
|
Bone Density | 1 | 2011 | 3425 | 0.010 |
Why?
|
Heart Ventricles | 1 | 2010 | 3837 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2013 | 14903 | 0.010 |
Why?
|
Tissue Donors | 1 | 2007 | 2159 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2016 | 12433 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2005 | 5038 | 0.010 |
Why?
|
Registries | 1 | 2012 | 8095 | 0.010 |
Why?
|
Chronic Disease | 1 | 2011 | 9047 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2011 | 15258 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2013 | 16017 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2011 | 22929 | 0.010 |
Why?
|
DNA | 1 | 2007 | 7166 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2011 | 18352 | 0.010 |
Why?
|
Graft Rejection | 1 | 2005 | 4411 | 0.010 |
Why?
|